And in our study, CD14+CD16+ monocyte, which represents the pro-inflammation phenotype, and the proportion of CD14+CD16+ monocyte in monocyte showed a suggestive causal association with increased risk in MS. The gene discussed is CD14; the disease is myeloid sarcoma.